Workup for Secondary Hypertension with Low Bicarbonate
Screen immediately for primary aldosteronism with an aldosterone-to-renin ratio (ARR), as this 36-year-old male meets multiple criteria for screening and the low bicarbonate (metabolic alkalosis) strongly suggests mineralocorticoid excess. 1
Why Primary Aldosteronism is the Priority
This patient's presentation is highly suggestive of primary aldosteronism (PA):
- Age <40 years is a specific indication for PA screening 1
- Low bicarbonate (19) actually represents metabolic alkalosis when corrected (corrected HCO3- = Na - Cl - 12), which is a hallmark of aldosterone excess 2
- Normal potassium (4.0) does NOT exclude PA—the majority of PA patients are normokalemic, and hypokalemia has low negative predictive value 1
The 2025 AHA/ACC guidelines specifically recommend PA screening in young-onset hypertension (age <30 years) and may be considered in stage 2 hypertension 1. At age 36, this patient warrants aggressive evaluation.
Specific Workup Algorithm
Step 1: Initial Screening Tests
Order these tests now:
- Aldosterone-to-renin ratio (ARR) - the primary screening test 1, 3
- Serum electrolytes - review for any prior potassium levels
- Basic metabolic panel - calculate corrected HCO3- (Na - Cl - 12)
- Plasma creatinine and eGFR - assess renal function 3
- Urinalysis with albumin-to-creatinine ratio 3
Step 2: Medication Adjustments Before ARR Testing
Critical pitfall: Many antihypertensives interfere with ARR accuracy 3:
- Stop these drugs (cause false negatives): ACE inhibitors, ARBs, beta-blockers, potassium-sparing diuretics, potassium-wasting diuretics
- May continue: Calcium channel blockers (though short-acting dihydropyridines can cause false negatives)
- Avoid: NSAIDs, alpha-2 agonists (cause false positives)
- Ideally discontinue interfering medications for 2-4 weeks before testing
Step 3: Additional Secondary Hypertension Screening
Given his age and presentation, also screen for:
Obstructive sleep apnea (OSA) - validated questionnaire initially, then overnight polysomnography if positive 1, 3
- OSA is present in up to 60% of resistant hypertension cases 3
- Consider especially if non-dipping pattern on ambulatory BP monitoring
Renovascular hypertension - if age <40 suggests fibromuscular dysplasia 3
- Renal artery Doppler ultrasound with resistive index
- Consider CT or MRI angiography if Doppler abnormal
24-hour urinary metanephrines - if any paroxysmal symptoms, headaches, palpitations 3
Step 4: If ARR is Positive
ARR >20-40 (depending on lab units) suggests PA 1:
- Proceed to confirmatory testing (saline suppression test, captopril challenge, or oral sodium loading)
- Adrenal CT imaging to identify adenomas 3
- Adrenal venous sampling if surgical candidate to lateralize aldosterone production 1
Why the Low Bicarbonate Matters
The bicarbonate of 19 appears low but represents metabolic alkalosis in the context of hyperaldosteronism. Recent evidence shows that corrected HCO3- correlates strongly with plasma aldosterone concentration in unilateral PA (aldosterone-producing adenoma), with 96.7% of patients having unilateral disease when PAC ≥150 pg/mL and cHCO3- ≥28 mmol/L 2. This makes the metabolic alkalosis a useful marker of disease activity.
Treatment Implications
If PA is confirmed:
- Unilateral adenoma: Laparoscopic adrenalectomy offers potential cure 1, 4
- Bilateral hyperplasia: Mineralocorticoid receptor antagonists (spironolactone or eplerenone) 3
Early diagnosis is crucial because PA causes cardiovascular and kidney damage independent of blood pressure effects, and targeted treatment improves outcomes 1, 5.